ANIX Anixa Biosciences Inc.

3.95
-0.11  -3%
Previous Close 4.06
Open 4.1
Price To Book 13.62
Market Cap 82,243,756
Shares 20,821,204
Volume 96,217
Short Ratio
Av. Daily Volume 82,614
Stock charts supplied by TradingView

NewsSee all news

  1. Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

    SAN JOSE, Calif., Jan. 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from

  2. Anixa Biosciences to Present at Biotech Showcase 2020

    SAN JOSE, Calif., Dec. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its

  3. Anixa Biosciences Announces Commercial Launch of Cchek™ Prostate Cancer Confirmatory Test

    SAN JOSE, Calif., Dec. 16, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the

  4. Anixa Biosciences to Host Conference Call to Discuss Plans for 2020

    SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will

  5. Anixa Biosciences Provides Update on CAR-T Program

    SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced an update

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Breast cancer vaccine

Latest News

  1. Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

    SAN JOSE, Calif., Jan. 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from

  2. Anixa Biosciences to Present at Biotech Showcase 2020

    SAN JOSE, Calif., Dec. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its

  3. Anixa Biosciences Announces Commercial Launch of Cchek™ Prostate Cancer Confirmatory Test

    SAN JOSE, Calif., Dec. 16, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the

  4. Anixa Biosciences to Host Conference Call to Discuss Plans for 2020

    SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will

  5. Anixa Biosciences Provides Update on CAR-T Program

    SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced an update

  6. Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

    SAN JOSE, Calif., Dec. 2, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from

  7. Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Nov. 26, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the addition

  8. Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Nov. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced a

  9. Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Nov. 20, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced its

  10. Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

    SAN JOSE, Calif., Nov. 7, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from

  11. Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

    SAN JOSE, Calif., Nov. 5, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that the

  12. Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Oct. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced its

  13. Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

    SAN JOSE, Calif., Oct. 15, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the

  14. Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

    SAN JOSE, Calif., Oct. 10, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced the appointment of Ian H.

  15. Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Sept. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that Mohummad Siddiqui,

  16. Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

    SAN JOSE, Calif., Sept. 19, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that Potomac Urology

  17. Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

    SAN JOSE, Calif., Sept. 16, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, congratulates H. Michael Shepard, Ph.D.,

  18. Anixa Biosciences to Present at Two Upcoming Investor Conferences

    SAN JOSE, Calif., Aug. 26, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ:ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced its participation at two